Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artytend is a nutraceutical food supplement developed by Jointherapeutics, specifically formulated to support the health and structural integrity of tendons and ligaments. The product contains a comprehensive blend of active ingredients, including *Boswellia sacra* extract, glucosamine, chondroitin, collagen, bromelain, manganese, selenium, and vitamins D and K. Its mechanism of action involves providing essential structural precursors for connective tissue repair (collagen, glucosamine, chondroitin) while modulating inflammatory pathways through the inhibition of 5-lipoxygenase by Boswellia and the proteolytic activity of bromelain. Additionally, the inclusion of specific vitamins and minerals supports bone metabolism and antioxidant defense. Artytend is intended for individuals experiencing tendon or ligament issues or those looking to maintain musculoskeletal health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Artytend.